以嶺藥業(002603.SZ):“益智安神片”新藥註冊申請已獲正式受理
格隆匯6月8日丨以嶺藥業(002603.SZ)公佈,近日,公司收到國家藥品監督管理局下發的《受理通知書》,由公司提交的“益智安神片”新藥註冊申請已獲正式受理。
益智安神片是公司根據中華通絡養生八字經理論指導失眠症病機治法研製的中藥新藥。功能主治為:益腎健腦、養心安神。用於失眠症,證屬腎精虧虛、心血不足、神識失養,症見夜寐不安、入睡困難、睡而易醒、早醒、睡眠時間短、多夢,神疲、乏力、健忘、頭暈、心悸、腰膝痠軟者等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.